RAC
Click for more information
1.11% $1.83 race oncology ltd

Answering Warnies question, my understanding is when drug...

  1. sjb71
    300 Posts.
    lightbulb Created with Sketch. 7
    clock Created with Sketch.
    15/01/19
    15:45
    Post #: 37121590

    Answering Warnies question, my understanding is when drug companies merge, they often rationalise the research programs of drugs they are developing to prioritise the ones they see have bigger potential in treatment segments, plus save $$. I believe this was the case with Bisantrene.



    RAC Price at posting: 9.6¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

PDN Paladin flags up to 4.5Mlbs of uranium production in FY25 guidance
right-arrow Created with Sketch.
NEWS Microcap Wrap: 5 explorers with news out today
right-arrow Created with Sketch.
RMS Ramelius boosts WA gold portfolio with stake in Spartan
right-arrow Created with Sketch.
SUN ANZ deal to buy Suncorp to go ahead following approval from Treasurer
right-arrow Created with Sketch.
SXL Southern Cross says no to buy up of Australian Community Media assets
right-arrow Created with Sketch.
TBN Tamboran is developing the NT Beetaloo Basin. To get there, it's listing at $36/sh on the NYSE
right-arrow Created with Sketch.
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.83 		Change
0.020(1.11%) 		Mkt cap ! $310.7M
Open High Low Value Volume
$1.81 $1.83 $1.79 $142.0K 78.77K

Buyers (Bids)

No. Vol. Price($)
1 500 $1.81
 

Sellers (Offers)

Price($) Vol. No.
$1.83 641 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.